Ryan Jason — SEC Form 4 filings
SEC reporting owner CIK 1585017. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-09 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 2 filings — 86,222 shares, $8,312,680 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 24,784 shares @ $71.35 ($1,768,420) in GeneDx Holdings Corp., filed 2024-11-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | Director | 7 | — | 13 legs · 86,222 sh · $8,312,680 | 10 |
| Singular Genomics Systems, Inc. (OMIC) | Director | 2 | — | — | 5 |
| SomaLogic, Inc. (SLGC) | Director | 1 | — | — | 3 |
Form 4 filings — Ryan Jason
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 3,576 @ $0 · Option exercise (M): 3,576 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | GeneDx Holdings Corp. (WGS) | Sale (S): 8,818 @ $125.07 · Sale (S): 8,969 @ $126.15 · Sale (S): 5,443 @ $127.44 · Sale (S): 3,452 @ $128.04 · Sale (S): 9,890 @ $129.59 · Sale (S): 1,500 @ $130.01 · +1 more | EDGAR |
| 2025-06-23 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 12,924 @ $0 · Grant/award (A): 3,576 (derivative) @ $0 · Option exercise (M): 12,924 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Singular Genomics Systems, Inc. (OMIC) | Disposition to issuer (D): 1,333 (derivative) @ $0 · Disposition to issuer (D): 1,541 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $8.84 | EDGAR |
| 2024-11-21 | 4 | GeneDx Holdings Corp. (WGS) | Gift (G): 141,356 @ $0 · Sale (S): 5,952 @ $70.86 · Sale (S): 24,784 @ $71.35 · Sale (S): 774 @ $72.26 · Sale (S): 9,361 @ $68.36 · Sale (S): 1,857 @ $69.84 · +1 more | EDGAR |
| 2024-10-17 | 4 | GeneDx Holdings Corp. (WGS) | Option exercise (M): 130 · Option exercise (M): 130 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | GeneDx Holdings Corp. (WGS) | Grant/award (A): 12,924 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Singular Genomics Systems, Inc. (OMIC) | Grant/award (A): 74,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | GeneDx Holdings Corp. (WGS) | Gift (G): 73,614 @ $0 | EDGAR |
| 2024-01-09 | 4 | SomaLogic, Inc. (SLGC) | Disposition to issuer (D): 185,400 (derivative) · Disposition to issuer (D): 14,650 (derivative) · Disposition to issuer (D): 3,400 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1585017 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →